Worth Venture Partners, LLC
- SEC CIK
- 0001696778
- Latest filing
- Aug 10, 2026
APRE holding history
Aprea Therapeutics, Inc. in every 13F filed by Worth Venture Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APRE overviewAll 13F holders of APREFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −87,169−100.0% | Sold out | Holders |
| Q4 2023 | 87,169 | $409.7K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 87,169 | $365.2K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 87,169 | $274.6K | 0.2% | +2,300+2.7% | Added | Holders |
| Q1 2023 | 84,869 | $377.7K | 0.2% | +84,869 | New | Holders |